Winston & Strawn and Taylor Wessing UK to Combine, Creating a Premier Transatlantic Law Firm
Winston & Strawn and Taylor Wessing’s UK-led business announced today their intention to combine, creating a premier transatlantic law firm that would operate under a new shared name, Winston Taylor. The combination responds to increasing client demand for seamlessly integrated US–UK–EU counsel for the businesses, people, and markets driving capital and innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215914957/en/
The combination once final will unite two international firms with more than 400 years of combined history, complementary strengths, and a common vision to meet clients’ evolving global needs. The combined firm will include more than 1,400 lawyers, establishing one of the largest transatlantic firms whose footprint is primarily in the United States, the United Kingdom, and Europe, and also in Latin America and the Middle East.
Leveraging significant strength and scale in major litigation, critical transactions, strategic IP, and private wealth, Winston Taylor will deliver best-in-class client service across key sectors including technology, life sciences, and financial services. Clients will gain a unified team with end-to-end capabilities across jurisdictions to achieve their business objectives in the breakthrough moments across their lifecycle.
“Once combined, we will have a London-headquartered partner that fulfills our long-held ambition to grow in the UK, while preserving the culture, agility, focus, and relentless client service that define Winston & Strawn,” said Steve D’Amore, Chairman of Winston & Strawn, who will continue as Chairman of the combined firm. “This combination will establish an elite practice in the major commercial centers important to our clients. Winston Taylor will be positioned to lead on the most sophisticated litigation and transactions in the world’s most defining industries.”
"In Winston & Strawn, Taylor Wessing UK will have a US partner that shares our vision, our values, and culture, and absolute focus on the highest levels of client service," said Shane Gleghorn, Managing Partner of Taylor Wessing UK, who will serve as Managing Partner of Europe and Middle East for Winston Taylor and will become a member of its Executive Committee. "By combining Winston & Strawn’s strength in the major hubs across the United States with our coverage of the key centers of London, Europe, and the Middle East we will have created a firm with the highest level of transatlantic capabilities in key practices and sectors."
Winston Taylor, once formed, will bring together two firms with aligned practices, shared clients, and cultures rooted in innovation and exceptional client service. The combined firm’s expanded corporate, private equity, real estate, finance, antitrust, regulatory, and private wealth capabilities will provide clients with end-to-end global business strategy and support. In addition, the combination of Taylor Wessing UK’s Tier 1 UK–EU holistic IP practice with Winston & Strawn’s premier U.S. intellectual property litigation practice will establish a market-leading transatlantic IP platform.
As part of the combination, Taylor Wessing the Netherlands and Belgium will enter into an agreement with Winston Taylor to operate under the Winston Taylor brand.
Completion of the combination is expected in May 2026, subject to approvals and a vote of the partners in each firm. Until then, they will operate as separate firms in the normal course. Upon closing, Taylor Wessing UK and Taylor Wessing the Netherlands and Belgium would depart the Taylor Wessing verein and Winston Taylor would seek to have a cooperation and referral relationship with the Taylor Wessing verein to provide continuity of support to clients.
Notes to editors
The combined business will have 20 offices in Amsterdam, Brussels, Cambridge, Charlotte, Chicago, Dallas, Dubai, Dublin, Eindhoven, Houston, Liverpool, London, Los Angeles, Miami, New York, Paris, San Francisco, São Paulo, Silicon Valley, and Washington DC.
For more information, visit www.winstontaylor.com.
AboutWinston & Strawn
Founded in 1853, Winston & Strawn is an Am Law 50 firm with ~1,000 lawyers across 14 offices worldwide. The firm is recognized for its leadership in litigation, intellectual property, corporate and finance transactions, and regulatory work across major sectors, including technology, life sciences, and financial services.
About Taylor Wessing UK
Founded in 1782, Taylor Wessing UK is a Top 20 UK law firm with over 450 lawyers in the UK, Ireland and the Middle East. The firm is renowned for its Tier 1 intellectual property, life sciences, technology, and private wealth practices, advising clients ranging from global corporations to leading innovators and investors.
About Taylor Wessing the Netherlands and Belgium
Taylor Wessing the Netherlands and Belgium brings together its Amsterdam, Eindhoven, and Brussels offices into a fully integrated Benelux practice, with over 100 lawyers and civil-law notaries advising high-growth technology and life sciences companies, multinational corporates, and investors on corporate transactions, intellectual property, disputes, and regulatory matters.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251215914957/en/
Contacts
WinstonTaylor@infiniteglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 04:41:00 EET | Press release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 03:15:00 EET | Press release
Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly three years, while adding a seasoned in-country team spanning operations, support, sales, finance, and leadership to enable rapid integration and future growth. The E
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 23:10:00 EET | Press release
IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerstone of IonQ’s global strategy,” said Niccolo de Masi, Chairman and CEO of IonQ. “QuantumBasel continues to be a critical innovation node for our company as
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 22:50:00 EET | Press release
Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which translate into thinner, more discreet and comfortable products. Its high compression capability enables s
SES Acknowledges Moody’s Rating Action and Reiterates Deleveraging Commitments17.12.2025 22:36:00 EET | Press release
SES S.A. (“SES” or the “Company”), a leading space solutions company, acknowledges the credit rating action announced by Moody’s Investor Service today, which follows the release of SES’ Q3 2025 results and Intelsat integration update. SES management reiterates that the Company continues to execute on its strategy with a clear plan to strengthen its key credit metrics over time. Consistent with this plan, it remains management’s intention to de-lever and return to credit metrics that are commensurate with investment grade, with a policy objective of reducing adjusted net leverage1 to at least 3.0x or below. Today’s rating action does not change the Company’s ability to operate its business, serve customers, or execute its strategic plan. SES maintains a balanced weighted average debt maturity profile of approximately five years, and the rating action from Moody’s is not expected to have a material impact on the interest payable under the Company’s existing debt facilities. SES also ben
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom